Carlsmed (CARL) Price to FCF (2025 - 2026)

Carlsmed's (CARL) quarterly Price to FCF came in at 35.39 in Q2 2026, down 88.94% quarter-over-quarter from 18.73 in Q1 2026.

Analysis

Carlsmed (CARL) Price to FCF (2025 - 2026) Analysis & Trends

Carlsmed (CARL) has reported Price to FCF for 2 consecutive years, with 35.39 the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Price to FCF changed N/A year-over-year to 35.39; the trailing twelve-month figure through Jun 2026 stood at 8.03 (changed N/A YoY), and the FY2025 full-year result was 5.92, changed N/A from the prior year.
Price to FCF eased to 35.39 in Q2 2026 per CARL's latest filing, from 18.73 in the prior quarter.
Across five years, Price to FCF topped out at 18.73 in Q1 2026 and bottomed at 35.39 in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn
9	Resmed	32.94 Bn	31.47 Bn	861.22 Mn
10	Carlsmed	424.72 Mn	311.42 Mn	14.54 Mn

Historic Data

Download Data